Sorry, these two links were supposed to go with my last reply. Couple of articles worth a read for anyone interested in pricing approaches in china. Another smaller bite, bigger piece of the pie market.
https://www.fiercepharma.com/marketing/keytruda-has-a-blockbuster-market-not-factored-into-merck-s-forecasts-china-analyst
https://www.fiercepharma.com/pharma-asia/merck-follows-opdivo-s-suit-prices-keytruda-china-at-half-its-u-s-tag-report
Sorry, these two links were supposed to go with my last reply....
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
-0.010(0.81%) |
Mkt cap ! $202.7M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.14 | $381.6K | 320.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 2171 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
-0.010 ( 5.54 %) |
||||
| Open | High | Low | Volume | ||
| $1.23 | $1.23 | $1.14 | 48407 | ||
| Last updated 15.52pm 03/05/2024 ? | |||||
| RAC (ASX) Chart |